Healthcare entity
All 3 tracked stories fall under one category: market-trends. Of the tracked stories, 2 of 3 also mention Exact Sciences, the most common co-covered peer. Source depth averages 2.3 original sources per story, versus 3.3 across the same-window beat baseline.
Last mentioned: 2d ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 33 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 3 tracked stories fall under one category: market-trends. Of the tracked stories, 2 of 3 also mention Exact Sciences, the most common co-covered peer. Source depth averages 2.3 original sources per story, versus 3.3 across the same-window beat baseline. The 5.3 average consequence score is below the beat benchmark of 6 in the same window. Seeking Alpha appears in 3 tracked Healthcare stories published from March 14, 2026 through March 17, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 84 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Seeking Alpha. Shared-story counts are live from our verified record — not editorial picks.
A sharp sell-off in mid-cap healthcare stocks has pushed several key players into technically oversold territory as geopolitical tensions in the Middle East trigger a broader market retreat. Investors are rotating out of riskier mid-sized equities, creating potential entry points for value-oriented healthcare analysts.
Source: Seeking Alpha
Mid-cap healthcare stocks are seeing a significant re-rating as quantitative models prioritize profitable growth and upward analyst revisions. Following a strong earnings season, the diagnostic and med-tech sub-sectors have emerged as the primary drivers of sector outperformance.
Source: Seeking Alpha · Seeking Alpha
Following the latest earnings cycle, Seeking Alpha's quantitative analysis identifies a significant performance gap between biopharma innovators and retail pharmacy giants. While Incyte and UnitedHealth lead with near-perfect scores, Walgreens and Moderna have fallen into 'Strong Sell' territory.
Source: Seeking Alpha · Seeking Alpha
Seeking Alpha is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
